Otello Stampacchia

CIK: 0001361712

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMA

ImageneBio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

IMA
ImageneBio, Inc.
Jun 16, 2026
Award(A)
Stock Option (right to buy)
Direct
15.6K shares-
IMA
ImageneBio, Inc.
Jul 25, 2025
Exercise(M)
Direct
379 shares-
IMA
ImageneBio, Inc.
Jul 25, 2025
Purchase(P)
Indirect
267.6K shares at avg. $29.90$8.0M

		Type	Shares	Price		Ownership
Jun 16, 2026	IMA ImageneBio, Inc.	Award(A) Stock Option (right to buy)	15,600	-	-	Direct
Jul 25, 2025	IMA ImageneBio, Inc.	Exercise(M)	379	-	-	Direct
Jul 25, 2025	IMA ImageneBio, Inc.	Purchase(P)	267,556	$29.90	$7,999,924	Indirect

1-3 of 3 transactions

About Stampacchia Otello

Stampacchia Otello (SEC CIK 0001361712) files insider reports with the SEC as Director of ImageneBio, Inc. (IMA).

Signal8 holds 2 ownership filings by Stampacchia Otello, all Form 4s, filed between Jul 30, 2025 and Jun 18, 2026. Those filings report 3 transactions, from Jul 25, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Stampacchia Otello's filings is in SAN DIEGO, CA.

Recent filings by Stampacchia Otello

Jun 16, 2026: Grant or award of IMA derivative securities (Form 4, code A).
Jul 25, 2025: Option exercise of IMA shares (Form 4, code M).
Jul 25, 2025: Open-market purchase of IMA shares (Form 4, code P).

Other insiders filing for ImageneBio, Inc. (IMA)

Yarema Kristin, Chief Executive Officer
Grant-Huerta Yanina, Chief Financial Officer
Lally Robert B, Principal Accounting Officer
Wang Jonathan Jian, Director
SLATTERY JOSEPH P, Director
Bonita David P, Director

How to read Form 4 transaction codes